182 related articles for article (PubMed ID: 31607331)
1. [Diagnostic Value of G and GM Tests in Acute Leukemia Patients with Invasive Fungal Disease].
Qian KY; Lyu QX; Dai LJ; Chang HR; Wu DP; Sun AN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1678-1681. PubMed ID: 31607331
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
3. Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
Fisher BT; Westling T; Boge CLK; Zaoutis TE; Dvorak CC; Nieder M; Zerr DM; Wingard JR; Villaluna D; Esbenshade AJ; Alexander S; Gunn S; Wheat LJ; Sung L
J Pediatric Infect Dis Soc; 2021 Sep; 10(8):864-871. PubMed ID: 34173659
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of invasive fungal disease in hospitalized patients with chronic obstructive pulmonary disease.
Mohedano Del Pozo RB; Rubio Alonso M; Cuétara García MS
Rev Iberoam Micol; 2018; 35(3):117-122. PubMed ID: 30078525
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
[TBL] [Abstract][Full Text] [Related]
6. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.
Ceesay MM; Desai SR; Berry L; Cleverley J; Kibbler CC; Pomplun S; Nicholson AG; Douiri A; Wade J; Smith M; Mufti GJ; Pagliuca A
Br J Haematol; 2015 Jan; 168(2):219-29. PubMed ID: 25179933
[TBL] [Abstract][Full Text] [Related]
8. [Early antigen diagnosis of invasive fungal infection in patients with hematological malignancies and patients receiving hematopoietic stem cell transplantation].
Xu J; Sun ZM; Wang XB; Zhang XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1302-5. PubMed ID: 21129281
[TBL] [Abstract][Full Text] [Related]
9. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
Zeng SY; Liu T; Meng WT; Chen YN
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
[TBL] [Abstract][Full Text] [Related]
10. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
12. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
[TBL] [Abstract][Full Text] [Related]
13. [A clinical analysis of micafungin treatment of pulmonary invasive fungal infection in pediatric patients with acute leukemia or post hematopoietic stem cells transplantation].
Huang K; Qiu KY; Deng LL; Fang JP; Li Y; Guo HX; Zhou DH
Zhonghua Er Ke Za Zhi; 2017 Nov; 55(11):844-847. PubMed ID: 29141316
[No Abstract] [Full Text] [Related]
14. [Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].
Liu L; Li J; Dong H; Jiang L; Song H; Zhang S; Zhang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):331-335. PubMed ID: 30914095
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit.
Talento AF; Dunne K; Joyce EA; Palmer M; Johnson E; White PL; Springer J; Loeffler J; Ryan T; Collins D; Rogers TR
J Crit Care; 2017 Aug; 40():119-127. PubMed ID: 28384600
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
17. The values of (1,3)-β-D-glucan and galactomannan in cases of invasive fungal rhinosinusitis.
Wei H; Li Y; Han D; Wang X; Liu X; He S; Lu X
Am J Otolaryngol; 2021; 42(2):102871. PubMed ID: 33412381
[TBL] [Abstract][Full Text] [Related]
18. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
[TBL] [Abstract][Full Text] [Related]
19. [Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan assay in invasive fungal infection].
Yu J; Li RY; Gao LJ; Lu QY; Wang XH
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):371-4. PubMed ID: 20367931
[TBL] [Abstract][Full Text] [Related]
20. Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.
Giacobbe DR; Del Bono V; Viscoli C; Mikulska M
Expert Rev Anti Infect Ther; 2017 Dec; 15(12):1101-1112. PubMed ID: 29125373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
